Understanding how different patients respond to septic shock treatment
Informing the Emergency Care of Septic Shock Patients: A Novel Application of Data-Driven Analytics
This study is looking at how different people with septic shock respond to treatments, focusing on their unique traits and genetics, to help find better and more personalized ways to help everyone recover.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11081820 on NIH RePORTER |
What this research studies
This research investigates the varying responses of patients with septic shock to treatments, focusing on both clinical and genetic factors. By utilizing advanced data analytics, the study aims to identify distinct patient phenotypes and the genetic variations that may influence treatment outcomes. The goal is to enhance the understanding of why some patients respond better to certain therapies than others, particularly among different racial groups. This research could lead to more personalized and effective treatment strategies for septic shock patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with septic shock, particularly those from diverse racial backgrounds.
Not a fit: Patients who do not have septic shock or those with other unrelated medical conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment protocols that significantly reduce mortality rates in septic shock patients.
How similar studies have performed: Other research has shown promise in using advanced analytics to improve patient outcomes in critical care settings, suggesting that this approach could yield valuable insights.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Black, Lauren Page — Northwestern University at Chicago
- Study coordinator: Black, Lauren Page
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.